UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000013006 |
|---|---|
| Receipt number | R000015097 |
| Scientific Title | Phase I study of cetuximab plus U3-1565 in colorectal cancer with resistance to anti-EGFR antibody |
| Date of disclosure of the study information | 2014/03/01 |
| Last modified on | 2020/02/03 10:29:38 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/01/29 11:56:08 | ||
| 2 | Update | 2014/08/03 14:02:49 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2014/08/03 14:03:19 | Email1 |
|
| 4 | Update | 2015/01/29 14:04:10 | Last name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person |
|
| 5 | Update | 2020/02/03 10:13:15 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Address Name of person sending information Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
| 6 | Update | 2020/02/03 10:17:29 | Recruitment status Date of IRB Last follow-up date |
|
| 7 | Update | 2020/02/03 10:27:57 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 8 | Update | 2020/02/03 10:29:38 | Date of IRB Last follow-up date |
